EPIQ Partners’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $725K | Hold |
13,912
| – | – | 0.37% | 46 |
|
2025
Q1 | $840K | Hold |
13,912
| – | – | 0.44% | 46 |
|
2024
Q4 | $952K | Buy |
13,912
+302
| +2% | +$20.7K | 0.52% | 44 |
|
2024
Q3 | $979K | Hold |
13,610
| – | – | 0.54% | 40 |
|
2024
Q2 | $943K | Buy |
13,610
+2,000
| +17% | +$139K | 0.64% | 38 |
|
2024
Q1 | $930K | Buy |
11,610
+1,147
| +11% | +$91.9K | 0.62% | 40 |
|
2023
Q4 | $1.15M | Hold |
10,463
| – | – | 0.82% | 34 |
|
2023
Q3 | $1.06M | Hold |
10,463
| – | – | 0.8% | 35 |
|
2023
Q2 | $1.42M | Hold |
10,463
| – | – | 0.97% | 34 |
|
2023
Q1 | $1.09M | Hold |
10,463
| – | – | 0.75% | 39 |
|
2022
Q4 | $927K | Hold |
10,463
| – | – | 0.62% | 43 |
|
2022
Q3 | $839K | Hold |
10,463
| – | – | 0.52% | 49 |
|
2022
Q2 | $1M | Hold |
10,463
| – | – | 0.61% | 50 |
|
2022
Q1 | $1.55M | Hold |
10,463
| – | – | 0.84% | 43 |
|
2021
Q4 | $1.48M | Hold |
10,463
| – | – | 0.79% | 45 |
|
2021
Q3 | $1.37M | Buy |
+10,463
| New | +$1.37M | 0.63% | 50 |
|